NCT00242008View on ClinicalTrials.gov

A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

December 31, 2004

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions

Parkinson's Disease

Interventions

DRUG

Rotigotine

Trial Locations (1)

Unknown

Schwarz, RTP

Sponsors

Lead Sponsor

All Listed Sponsors

lead

UCB Pharma

INDUSTRY